Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study

Autor: Kazumasa, Kurogi, Seigo, Sugiyama, Kenji, Sakamoto, Shinji, Tayama, Shinichi, Nakamura, Takeshi, Biwa, Kunihiko, Matsui, Hisao, Ogawa, Kazuki, Fukuda
Rok vydání: 2013
Předmět:
Adult
Male
medicine.medical_specialty
Statin
medicine.drug_class
Endpoint Determination
Lipoproteins
Atorvastatin
Hypercholesterolemia
Blood lipids
Hyperlipoproteinemia
Coronary Artery Disease
Gastroenterology
chemistry.chemical_compound
Young Adult
Internal medicine
medicine
Humans
Pyrroles
Pitavastatin
Aged
Hypolipidemic Agents
Aged
80 and over
medicine.diagnostic_test
Adiponectin
Apolipoprotein A-I
Cholesterol
business.industry
Cholesterol
HDL
nutritional and metabolic diseases
Middle Aged
medicine.disease
HDL-cholesterol lowering drugs
Endocrinology
chemistry
Heptanoic Acids
Cardiology
Quinolines
lipids (amino acids
peptides
and proteins)
Female
Hydroxymethylglutaryl-CoA Reductase Inhibitors
business
Lipid profile
Cardiology and Cardiovascular Medicine
Dyslipidemia
medicine.drug
Follow-Up Studies
Zdroj: Journal of Cardiology. 62(2):87-94
ISSN: 0914-5087
DOI: 10.1016/j.jjcc.2013.03.008
Popis: Background Many large-scale clinical trials have confirmed that statins are effective in reducing low-density lipoprotein cholesterol (LDL-C) level, resulting in reducing cardiovascular events. Recent studies have focused on the effects of statins on high-density lipoprotein cholesterol (HDL-C). Here we compared the effects of two statins on lipid profile and other metabolic parameters. Methods The study population included 129 patients with stable coronary artery disease, hypercholesterolemia, and hypo-HDL-cholesterolemia (HDL-C
Databáze: OpenAIRE
Externí odkaz: